electroCore Reports Record 2025 Sales, Strong 2026 Guidance, and CEO Transition

summarizeSummary

electroCore reported record 2025 net sales of $32.0 million, a 27% increase, and provided 2026 revenue guidance of approximately 30% growth, alongside announcing the retirement of its CEO and new executive appointments.

check_boxKey Events

• Record 2025 Net Sales Reported

  The company achieved record full-year 2025 net sales of $32.0 million, representing a 27% increase over $25.2 million in 2024, driven by strong U.S. prescription and general wellness sales.

• Positive 2026 Revenue Guidance Issued

  electroCore provided full-year 2026 revenue guidance projecting approximately 30% annual growth over 2025.

• CEO Retirement and Leadership Transition

  CEO Dan Goldberger will retire effective April 1, 2026. Joshua Lev, the current CFO, will assume the role of interim President, and Michael Fox has been hired as Chief Operating Officer.

• Improved Adjusted EBITDA Net Loss

  The adjusted EBITDA net loss for full-year 2025 was $8.7 million, a slight improvement compared to $9.0 million in 2024.

auto_awesomeAnalysis

electroCore, Inc. announced robust financial results for 2025, including record net sales and positive revenue growth guidance for 2026, indicating continued operational momentum. The company also disclosed a significant leadership transition with the retirement of its CEO and the appointment of an interim President and a new Chief Operating Officer. While the CEO's departure introduces some change, the planned nature of the transition, the appointment of the CFO as interim President, and the hiring of an experienced COO suggest a strategic move to strengthen leadership for future growth. Investors will likely focus on the company's ability to maintain its growth trajectory under the new leadership.